New Delhi, July 26, 2022 (GLOBE NEWSWIRE) -- Global Peptide and Anticoagulant Drugs Market is flourishing owing to the rising number of cardiovascular diseases and technological advancements along with the emergence of new markets…
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Global Peptide and Anticoagulant Drugs Market is projected to grow at a CAGR of 5.4%, earning revenues of around USD 2.15 billion by the end of 2028. The Global Peptide and Anticoagulant Drugs Market is booming because the prevalence of the chronic disease is rising internationally, in every region, and across all socioeconomic strata. Thus, the requirement for efficient therapies is accelerated by the rising prevalence of chronic diseases, which is anticipated to fuel the market for peptide and anticoagulant medications. Moreover, the market for peptides and anticoagulants is predicted to grow as a result of rising rates of ischemic heart disease, venous thromboembolism (VTE), and awareness of innovative oral anticoagulants (NOACs). Furthermore, Global Peptide and Anticoagulant Drugs Market is one of the most emerging markets that grow continuously owing to the rising public awareness of the benefits of early diagnostics. However, the high level of market consolidation and the availability of alternative drugs are impeding the global growth of the Peptide and Anticoagulant Drugs Market.
Increasing Number of Cardiovascular Diseases
Increased prevalence of cardiovascular illnesses encourages further industry growth. Due to the rise in cardiovascular disorders, the industry is expanding. The market is growing mostly as a result of cardiovascular issues. Cardiovascular diseases are the biggest cause of death worldwide, accounting for almost 18.6 million deaths in 2019, according to the Heart Disease and Stroke Statistics Update Fact Sheet published in 2021. Annually, cardiovascular disorders claim more lives than cancer and chronic lower respiratory disease (CLRD) combined. The increased prevalence of chronic diseases in both elderly and middle-aged populations is another factor that is expected to quicken the market's rate of expansion. Additionally, the aging of the world's population is expected to spur growth in the market for peptide and anticoagulant drugs.
Technology Advancement Fuels Market Expansion
Anticoagulant product development technology advances are anticipated to help the market. According to a study that was released in the Frontier in Biotechnology and Bioengineering in December 2019, highly accurate, durable, and affordable anticoagulant products have been created using cutting-edge technologies like microfluidics, fluorescent microscopy, electrochemical sensing, photoacoustic detection, and micro/nano electromechanical systems (MEMS/NEMS). The market is also growing as a result of a rise in R&D efforts and the emergence of new markets. These elements will create favorable conditions for the market expansion of peptide and anticoagulant medicines.
Request for Sample Report @ https://www.blueweaveconsulting.com/report/peptide-and-anticoagulant-drugs-market/report-sample
Challenge: Expensive Drug Development Procedures
The high costs associated with drug development and distribution, on the other hand, will slow the market's growth rate. The lack of healthcare infrastructure in developing economies, as well as a scarcity of skilled professionals, will pose a challenge to the peptide and anticoagulant drug markets. Furthermore, a lack of public awareness and stringent government regulations will restrain and impede the market's growth rate during the forecast period of 2022-2029.
Segmental Coverage
Global Peptide and Anticoagulant Drugs Market – By Product
Based on product, the Global Peptide and Anticoagulant Market is segmented into Hormonal, Antibiotic, ACE Inhibitor, Antifungal, and Others. Among these, the hormonal segment is expected to grow at the fastest rate during the forecast period. During puberty, menstruation, and pregnancy, hormonal imbalances are more common. However, external factors such as stress or hormone medications can cause hormonal imbalances. All these factors boost the growth of the India Brake Pad Market during the forecast period (2022-2028).
Please Visit the Press Release: https://www.blueweaveconsulting.com/press-release/global-peptide-and-anticoagulant-drugs-market-to-reach-usd-2-15-billion-by-2028
Impact of COVID-19 on Global Peptide and Anticoagulant Drugs Market
COVID-19 infection has a significant impact on the peptide and anticoagulant drug markets. More than ten clinical trials are underway to assess the potential of anticoagulants in COVID-19 patients, according to a study published in the American Journal of Cardiovascular Drugs in 2020, and research on parenteral administration strategies for these drugs for use in critically ill COVID-19 patients is being conducted. Furthermore, patients with COVID-19, both confirmed and suspected, should have access to follow-up care with low-dose anticoagulants, according to a World Health Organization Update published in January 2021. As a result, anticoagulant demand skyrocketed during COVID-19.
Competitive Landscape
The leading market players in the Global Peptide and Anticoagulant Drugs Market are F.Hoffmann-La Roche Ltd, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer, GSK, Novartis AG, Allergan, Eisai Co Ltd, Merck & Co Inc, and other prominent players. The Global Peptide and Anticoagulant Drugs Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Peptide and Anticoagulant Drugs Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Peptide and Anticoagulant Drugs Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Recent Development
- In December 2020, Takeda Pharmaceutical Company Limited and PeptiDream Inc. entered into collaborative research and exclusive license agreement to create peptide-drug conjugates (PDCs) for neuromuscular diseases.
- In December 2020, Natco Pharma announced the launch of an anticoagulant medication named Rivaroxaban (RPIGAT). Rivaroxaban is an anticoagulant drug that treats and prevents blood clots. In India, Bayer markets the drug as Xarelto.
Scope of the Report
| Attributes | Details |
| Years Considered | Historical data – 2018-2021 |
| Base Year – 2021 | |
| Forecast – 2022 – 2028 | |
| Facts Covered | Revenue in USD Billion |
| Product Service/Segmentation | By Route of Administration, By Product, By Application, By End-User, By Region |
| Key Players | F.Hoffmann-La Roche Ltd, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer, GSK, Novartis AG, Allergan, Eisai Co Ltd, Merck & Co Inc, and other prominent players |
By Route of Administration
- Parenteral
- Oral
- Mucosal
- Others
By Product
- Hormonal
- Antibiotic
- ACE Inhibitor
- Antifungal
- Others
By Application
-
- Diabetes
- Infectious Product
- Cancer
- Osteoporosis
- Cardiology
- Gynecology
By End-User
-
- Hospitals
- Clinics
- Homecare
- Others
By Region
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Please Find Below Some Related Topics:
- Interventional Radiology Products Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
- Medical Tapes and Bandages Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
- Laboratory Proficiency Testing Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
- Electrosurgery Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
- Veterinary Reference Laboratory Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
info@blueweaveconsulting.com
https://www.blueweaveconsulting.com/
https://www.linkedin.com/company/blueweaveconsulting/
